Skip to contentP
Phathom Pharmaceuticals, Inc.
P
PHATPhathom Pharmaceuticals, Inc. Q2 2023 · 10-Q
Revenue$0.00$0.00no prior Q2 2022 on file Net Income-$40.97M-$40.97MN/M vs Q2 2022 EPS Diluted-$0.84-$0.84N/M vs Q2 2022 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
Operating Cash Flowderived-$22,200,000N/M Free Cash Flowderived-$22,206,000N/M ended Jun 30, 2023 · filed Aug 10, 2023 · 41 d after period end